Suchergebnisse - "Thompson, Melanie A"

PubPharm (63)

1

Updated Treatment Recommendation on Use of Cabotegravir and Rilpivirine for People With HIV From the IAS-USA Guidelines Panel

enthalten in: JAMA | 2024

von Sax, P. | Thompson, M. | Saag, M. | +1

2

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults : 2022 Recommendations of the International Antiviral Society-USA Panel

enthalten in: JAMA | 2023

von Gandhi, R. | Bedimo, R. | Hoy, J. | +15

3

Erratum to : Primary Care Guidance for Persons With Human Immunodeficiency Virus: 2020 Update by the HIV Medicine Association of the Infectious Diseases Society of America

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2022

von Thompson, M. | Horberg, M. | Agwu, A. | +5

ErratumFor: Clin Infect Dis. 2021 Dec 6;73(11):e3572-e3605. - PMID 33225349

4

Primary Care Guidance for Persons With Human Immunodeficiency Virus : 2020 Update by the HIV Medicine Association of the Infectious Diseases Society of America

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2021

von Thompson, M. | Horberg, M. | Agwu, A. | +5

ErratumIn: Clin Infect Dis. 2021 Dec 08;:. - PMID 34878522

5

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults : 2020 Recommendations of the International Antiviral Society-USA Panel

enthalten in: JAMA | 2020

von Saag, M. | Gandhi, R. | Hoy, J. | +13

CommentIn: JAMA. 2021 Mar 2;325(9):888-889. - PMID 33651085

6

Differential Plasma Protein Regulation and Statin Effects in Human Immunodeficiency Virus (HIV)-Infected and Non-HIV-Infected Patients Utilizing a Proteomics Approach

enthalten in: The Journal of infectious diseases | 2020

von deFilippi, C. | Toribio, M. | Wong, L. | +15

7

Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER) : primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial

enthalten in: Lancet (London, England) | 2020

von Mayer, K. | Molina, J. | Thompson, M. | +21

CommentIn: Lancet. 2020 Jul 25;396(10246):214-215. - PMID 32711780

8

Fixed-dose combination bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir-containing regimens for initial treatment of HIV-1 infection : week 144 results from two randomised, double-blind, multicentre, phase 3, non-inferiority trials

enthalten in: The lancet. HIV | 2020

von Orkin, C. | DeJesus, E. | Sax, P. | +20

CommentIn: Lancet HIV. 2020 Jun;7(6):e374-e375. - PMID 32504568

9

Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD) : 96-week results of a randomised, double-blind, non-inferiority, phase 3 trial

enthalten in: The lancet. HIV | 2020

von Molina, J. | Squires, K. | Sax, P. | +112

CommentIn: Lancet HIV. 2020 Jan;7(1):e2-e3. - PMID 31740350

10

Bictegravir combined with emtricitabine and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection : week 96 results from a randomised, double-blind, multicentre, phase 3, non-inferiority trial

enthalten in: The lancet. HIV | 2019

von Wohl, D. | Yazdanpanah, Y. | Baumgarten, A. | +11

CommentIn: Lancet HIV. 2019 Jun;6(6):e342-e343. - PMID 31068271

1
2
3
4
5
6
7
Nächster »
[7]